Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection

Detalhes bibliográficos
Autor(a) principal: Mussi,Thais Caldara
Data de Publicação: 2018
Outros Autores: Martins,Tatiana, Dantas,George Caldas, Garcia,Rodrigo Gobbo, Filippi,Renee Zon, Lemos,Gustavo Caserta, Baroni,Ronaldo Hueb
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000601129
Resumo: ABSTRACT Background: Dynamic-contrast enhanced (DCE) sequence is used to increase detection of small lesions, based on increased vascularization. However, literature is controversy about the real incremental value of DCE in detection of clinically significant (CS) prostate cancer (PCa), since absence of enhancement does not exclude cancer, and enhancement alone is not definitive for tumor. Purpose: To test the hypothesis that DCE images do not increase CS PCa detection on MRI prior to biopsy, comparing exams without and with contrast sequences. Material and Materials and Methods: All men who come to our institution to perform MRI on a 3T scanner without a prior diagnosis of CS PCa were invited to participate in this study. Reference standard was transrectal prostate US with systematic biopsy and MRI/US fusion biopsy of suspicious areas. Radiologists read the MRI images prospectively and independently (first only sequences without contrast, and subsequently the entire exam) and graded them on 5-points scale of cancer suspicion. Results: 102 patients were included. Overall detection on biopsy showed CS cancer in 43 patients (42.2%), clinically non-significant cancer in 11 (10.8%) and negative results in 48 patients (47%). Positivities for CS PCa ranged from 8.9% to 9.8% for low suspicion and 75.0% to 88.9% for very high suspicion. There was no statistical difference regarding detection of CS PCa (no statistical difference was found when compared accuracies, sensitivities, specificities, PPV and NPV in both types of exams). Inter-reader agreement was 0.59. Conclusion: Exams with and without contrast-enhanced sequences were similar for detection of CS PCa on MRI.
id SBU-1_3b63c33170b2e00a4057e8009fec7084
oai_identifier_str oai:scielo:S1677-55382018000601129
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detectionMagnetic Resonance ImagingProstatic NeoplasmsMenABSTRACT Background: Dynamic-contrast enhanced (DCE) sequence is used to increase detection of small lesions, based on increased vascularization. However, literature is controversy about the real incremental value of DCE in detection of clinically significant (CS) prostate cancer (PCa), since absence of enhancement does not exclude cancer, and enhancement alone is not definitive for tumor. Purpose: To test the hypothesis that DCE images do not increase CS PCa detection on MRI prior to biopsy, comparing exams without and with contrast sequences. Material and Materials and Methods: All men who come to our institution to perform MRI on a 3T scanner without a prior diagnosis of CS PCa were invited to participate in this study. Reference standard was transrectal prostate US with systematic biopsy and MRI/US fusion biopsy of suspicious areas. Radiologists read the MRI images prospectively and independently (first only sequences without contrast, and subsequently the entire exam) and graded them on 5-points scale of cancer suspicion. Results: 102 patients were included. Overall detection on biopsy showed CS cancer in 43 patients (42.2%), clinically non-significant cancer in 11 (10.8%) and negative results in 48 patients (47%). Positivities for CS PCa ranged from 8.9% to 9.8% for low suspicion and 75.0% to 88.9% for very high suspicion. There was no statistical difference regarding detection of CS PCa (no statistical difference was found when compared accuracies, sensitivities, specificities, PPV and NPV in both types of exams). Inter-reader agreement was 0.59. Conclusion: Exams with and without contrast-enhanced sequences were similar for detection of CS PCa on MRI.Sociedade Brasileira de Urologia2018-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000601129International braz j urol v.44 n.6 2018reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2018.0102info:eu-repo/semantics/openAccessMussi,Thais CaldaraMartins,TatianaDantas,George CaldasGarcia,Rodrigo GobboFilippi,Renee ZonLemos,Gustavo CasertaBaroni,Ronaldo Huebeng2019-01-03T00:00:00Zoai:scielo:S1677-55382018000601129Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2019-01-03T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
title Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
spellingShingle Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
Mussi,Thais Caldara
Magnetic Resonance Imaging
Prostatic Neoplasms
Men
title_short Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
title_full Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
title_fullStr Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
title_full_unstemmed Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
title_sort Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection
author Mussi,Thais Caldara
author_facet Mussi,Thais Caldara
Martins,Tatiana
Dantas,George Caldas
Garcia,Rodrigo Gobbo
Filippi,Renee Zon
Lemos,Gustavo Caserta
Baroni,Ronaldo Hueb
author_role author
author2 Martins,Tatiana
Dantas,George Caldas
Garcia,Rodrigo Gobbo
Filippi,Renee Zon
Lemos,Gustavo Caserta
Baroni,Ronaldo Hueb
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mussi,Thais Caldara
Martins,Tatiana
Dantas,George Caldas
Garcia,Rodrigo Gobbo
Filippi,Renee Zon
Lemos,Gustavo Caserta
Baroni,Ronaldo Hueb
dc.subject.por.fl_str_mv Magnetic Resonance Imaging
Prostatic Neoplasms
Men
topic Magnetic Resonance Imaging
Prostatic Neoplasms
Men
description ABSTRACT Background: Dynamic-contrast enhanced (DCE) sequence is used to increase detection of small lesions, based on increased vascularization. However, literature is controversy about the real incremental value of DCE in detection of clinically significant (CS) prostate cancer (PCa), since absence of enhancement does not exclude cancer, and enhancement alone is not definitive for tumor. Purpose: To test the hypothesis that DCE images do not increase CS PCa detection on MRI prior to biopsy, comparing exams without and with contrast sequences. Material and Materials and Methods: All men who come to our institution to perform MRI on a 3T scanner without a prior diagnosis of CS PCa were invited to participate in this study. Reference standard was transrectal prostate US with systematic biopsy and MRI/US fusion biopsy of suspicious areas. Radiologists read the MRI images prospectively and independently (first only sequences without contrast, and subsequently the entire exam) and graded them on 5-points scale of cancer suspicion. Results: 102 patients were included. Overall detection on biopsy showed CS cancer in 43 patients (42.2%), clinically non-significant cancer in 11 (10.8%) and negative results in 48 patients (47%). Positivities for CS PCa ranged from 8.9% to 9.8% for low suspicion and 75.0% to 88.9% for very high suspicion. There was no statistical difference regarding detection of CS PCa (no statistical difference was found when compared accuracies, sensitivities, specificities, PPV and NPV in both types of exams). Inter-reader agreement was 0.59. Conclusion: Exams with and without contrast-enhanced sequences were similar for detection of CS PCa on MRI.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000601129
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000601129
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1677-5538.ibju.2018.0102
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.44 n.6 2018
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318076371402752